IQVIA™ Real-World Insights Bibliography

Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Portugal
Author(s): Nuno Marques 1, Laetitia Gerlier 2, Mafalda Ramos 3, Helder Pereira 4, Sérgia Rocha 5, Ana Catarina Fonseca 6, Ana André 7, Ricardo Melo 8, Eduard Sidelnikov 9
Affiliations(s): 1Department of Cardiology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 2IQVIA, Zaventem, Belgium. 3IQVIA, Zaventem, Belgium. Electronic address: mafalda.ramos@iqvia.com. 4Department of Cardiology, Hospital Garcia de Orta, Almada, Portugal. 5Department of Cardiology, Hospital de Braga, Braga, Portugal. 6Department of Neurology, Hospital de Santa Maria, Universidade de Lisboa, Lisboa, Portugal. 7Department of Neurology, Centro Hospitalar e Universitário do Algarve, Faro, Portugal. 8Amgen SA, Portugal. 9Amgen (Europe) GmbH, Rotkreuz, Switzerland.
Publication(s):  PMID: 33581948 DOI: 10.1016/j.repc.2020.05.019 IQVIA HEOR Zaventem Brussels
Revista Portuguesa de Cardiologia Volume 40, Issue 2, February 2021, Pages 109-115.
Document Type(s): Article,
Countries: Portugal,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2021
  L:
A:
English
Burden of illness, Clinical setting: Primary care, Prospective study,
  Add to report
 
 
Characterisation of Pulmonary Arterial Hypertension (PAH) Patients Initiating a New PAH Specific Therapy in the Context of Age: Insights from EXPOSURE
Author(s): P. Escribano (1), S. Gaine (2), P. Biedermann (3), A. Muller (3), M. Valge (4), T. Lange (5), S. Söderberg (6)
Affiliations(s): 1 Pulmonary Hypertension Unit, Cardiology Department, CIBERCV, Hospital 12 de Octubre, Madrid, Spain 2 National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland 3 Actelion Pharmaceuticals Ltd, Allschwil, Switzerland 4 StatFinn Estonia OÜ, Tartu, Estonia (now IQVIA) 5 University Medical Center Regensburg, Regensburg, Germany 6 Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden
Publication(s):  JO - The Journal of Heart and Lung Transplantation VL - 40 IS - 4, Supplement SP - S109 PY - 2021 DA - 2021/04/01/ SN - 1053-2498
Document Type(s): Abstract,
Countries: Canada, Europe,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2021
  L:
A:
English
Epidemiological study, Observational study,
  Add to report
 
 
Use of Low Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitors (PCSK9i) Initiation
Author(s): Rymer JA, Mues KE, Monda KL, Bratton EW, Wirtz HS, Okerson T, Overman RA, Brookhart MA, Muntner P, Wang TY
Affiliations(s): From the Duke Clinical Research InstituteDurham NC (J.A.R., T.Y.W.); Center for Observational ResearchAmgen IncThousand Oaks CA (K.E.M., K.L.M., H.S.W., T.O.); IQVIA, Real?World Evidence SolutionsDurham NC (E.W.B.); NoviSci, IncDurham NC (R.A.O., M.A.B.); University of North Carolina at Chapel HillChapel Hill NC (M.A.B.); Department of EpidemiologyUniversity of Alabama at BirminghamAL (P.M.).
Publication(s):  Originally published24 Apr 2020https://doi.org/10.1161/JAHA.119.014347Journal of the American Heart Association. ;0:e014347
Document Type(s): Article,
Countries: USA,
Click here for the abstract
C:
Y:
Cardiovascular disease, Medication compliance,
2020
  L:
A:
English
Epidemiological study,
  Add to report
 
 
Concomitant use of drugs known to cause interactions with oral antiplatelets?polypharmacy in acute coronary syndrome outpatients in Finland
Author(s): Tuire Prami, Houssem Khanfir, Pål Hasvold, Eeva Reissell, Juhani Airaksinen, Ville Kytö
Affiliations(s): Ville Kytö: Heart Center, Turku University Hospital
Publication(s):  European Journal of Clinical Pharmacology (2020) 76:257?265
Document Type(s): Article,
Countries: Finland,
Click here for the abstract
C:
Y:
Cardiovascular disease,
2020
  L:
A:
English
Population Based Study, Retrospective database analysis,
  Add to report
 
 
Évaluation de la population à risque d’hyperkaliémie
Author(s): Gilles Berrut1 Anne-Sophie Boureau1 Laure de Decker1 Olivier Hanon2
Affiliations(s): 1 Pôle hospitalo-universitaire de gérontologie clinique, CHU Nantes, France 2 Hôpitaux universitaires Paris Centre, Service de gériatrie, Hôpital Broca, Université Paris-Descartes, Paris, France
Publication(s):  10.1684/pnv.2020.0873
Document Type(s): Article,
Countries: 
Click here for the abstract
C:
Y:
Cardiovascular disease, Hematology,
2020
  L:
A:
French
Retrospective database analysis,
  Add to report
 
 
Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden
Author(s): Anna Castelo-Branco, Flaminia Chiesa, Camilla E Bengtsson , Sally Lee, Neil N Minton, Steve Niemcryk, Anders Lindholm, Mats Rosenlund, Fredrik Piehl, Scott Montgomery
Affiliations(s): 1.Real-world Insights, IQVIA Nordics, Solna, Sweden 2. Celgene Corporation, Summit, NJ, USA
Publication(s):  Mult Scler J Exp Transl Clin. 2020 Jul-Sep; 6(3): 2055217320947761. Published online 2020 Aug 14
Document Type(s): Article,
Countries: Sweden,
Click here for the abstract
C:
Y:
Cardiovascular disease, Neurological disorders, Patient Registries & Real-World Study Methods,
2020
  L:
A:
English
Epidemiological study, Observational study, Population Based Study, Retrospective cohort analysis,
  Add to report
 
 
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study
Author(s): Yutaka Seino*, Dae Jung Kim, Daisuke Yabe, Elise Chia-Hui Tan, Wook-Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement**, Atsutaka Yasui, Wei-Yu, Sunwoo Lee, Moe H Kyaw, Anouk Deruaz-Luyet, Kimberly G Brodovicz,Wayne H-H Sheu, on behalf of the EMPRISE East Asia study group
Affiliations(s): * Kansai Electric Power Medical Research Institute, Kobe, Japan and Kansai Electric Power Hospital, Osaka, Japan **EPID Research an IQVIA company, Tartu, Estonia
Publication(s):  Endocrinology, Diabetes and Metabolism 2020;00:e00183
Document Type(s): Article,
Countries: Japan, South Korea, Taiwan,
Click here for the abstract
C:
Y:
Cardiovascular disease, Diabetes,
2020
  L:
A:
English
Epidemiological study, Retrospective database analysis,
  Add to report
 
 
Health technology assessment submissions for cardiovascular interventions in the ASIA-Pacific region
Author(s): Ryo Mitsuo 1, Hiroyuki Matsuda 1, Krishant Chand 1, Eric Yu 1, Sven Demiya 1, Raf De Moor 1 (rwesheorj 1)
Affiliations(s): 1) IQVIA Solutions Japan K.K., Minato-ku, Tokyo, Japan
Publication(s):  ISPOR Asia Pacific 2020 Conference
Document Type(s): Abstract,
Countries: 
Click here for the abstract
C:
Y:
Cardiovascular disease,
2020
  L:
A:
English
Pricing & Reimbursement,
  Add to report
 
 
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients
Author(s): Goodall G1, Lamotte M2, Ramos M2, Maunoury F3, Pejchalova B1, de Pouvourville G4
Affiliations(s): 1 Edwards Lifesciences S.A., Nyon, Switzerland 2 IQVIA, Zaventem, Belgium 3 Statesia, Le Mans, France 4 ESSEC Business School, Cergy Pontoise, France
Publication(s):  J Med Econ. 2019 Apr;22(4):289-296. doi: 10.1080/13696998.2018
Document Type(s): Article,
Countries: France,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2019
  L:
A:
English
Cost effectiveness,
  Add to report
 
 
Patient and caregiver productivity loss and indirect costs associated with cardiovascular events in Europe
Author(s): Kotseva K1, Gerlier L2, Sidelnikov E3, Kutikova L3, Lamotte M2, Amarenco P4, Annemans L5
Affiliations(s): 1 Department of Cardiovascular Medicine, National Heart and Lung Institute, Imperial College London, UK 2 IQVIA, Zaventem, Belgium 3 Amgen (Europe) GmbH, Rotkreuz, Switzerland 4 Department of Neurology and Stroke Centre, Bichat Hospital, Paris, France 5 University of Ghent, Belgium
Publication(s):  Eur J Prev Cardiol. 2019 Jul;26(11):1150-1157.
Document Type(s): Article,
Countries: Belgium, France, Poland, Portugal, Spain, Switzerland, UK,
Click here for the abstract
C:
Y:
Cardiovascular disease, Health economics,
2019
  L:
A:
English
Burden of illness, Clinical setting: Primary care, direct to patient research, Observational study,
  Add to report
 
 
 1 of 51 Next Page Last Page